Capricor Therapeutics, Inc (CAPR) insider trading
Every open-market stock purchase and sale by Capricor Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $8.4M over the last 12 months (10 sales). No open-market buys.
- Last insider buy: Nippon Shinyaku Co Ltd (Insider), $15M, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $8.4M (10 sales). Last close $6.13 on Oct 22, 2026.
Recent CAPR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 25, 2026 | Karen Krasney (VP) | Sold | $732K |
| Jun 25, 2026 | Anthony Bergmann (CFO) | Sold | $732K |
| Jun 25, 2026 | Anthony Bergmann (CFO) | Bought (not open market) | — |
| Jun 25, 2026 | Karen Krasney (VP) | Bought (not open market) | — |
| Jun 24, 2026 | Anthony Bergmann (CFO) | Sold | $12K |
| Jun 24, 2026 | Karen Krasney (VP) | Sold | $12K |
| Jun 24, 2026 | Karen Krasney (VP) | Bought (not open market) | — |
| Jun 24, 2026 | Anthony Bergmann (CFO) | Bought (not open market) | — |
| Jun 22, 2026 | Karen Krasney (VP) | Sold | $15K |
| Jun 22, 2026 | Anthony Bergmann (CFO) | Sold | $15K |
| Jun 22, 2026 | Karen Krasney (VP) | Bought (not open market) | — |
| Jun 22, 2026 | Anthony Bergmann (CFO) | Bought (not open market) | — |
| May 26, 2026 | Michael T Maurer (C-suite exec) | Bought (not open market) | — |
| May 18, 2026 | Anthony Bergmann (CFO) | Bought (not open market) | — |
| May 13, 2026 | Frank Litvack (Insider) | Bought (not open market) | — |
| May 1, 2026 | Karen Krasney (VP) | Sold | $793K |
| May 1, 2026 | Anthony Bergmann (CFO) | Sold | $793K |
| May 1, 2026 | Anthony Bergmann (CFO) | Bought (not open market) | — |
| May 1, 2026 | Karen Krasney (VP) | Bought (not open market) | — |
| Apr 2, 2026 | Karimah Es Sabar (Insider) | Sold | $241K |
| Apr 2, 2026 | Karimah Es Sabar (Insider) | Bought (not open market) | — |
| Apr 1, 2026 | Karimah Es Sabar (Insider) | Sold | $1.7M |
| Apr 1, 2026 | Karimah Es Sabar (Insider) | Bought (not open market) | — |
| Mar 31, 2026 | Karimah Es Sabar (Insider) | Sold | $1.8M |
| Mar 31, 2026 | Anthony Bergmann (CFO) | Sold | $753K |
Who's trading CAPR
- Karen Krasney, VP: sold $2.3M (5 sales), last Jun 25, 2026
- Anthony Bergmann, CFO: sold $2.3M (5 sales), last Jun 25, 2026
- Michael T Maurer, C-suite exec: other filings, last May 26, 2026
- Frank Litvack, Insider: other filings, last May 13, 2026
- Karimah Es Sabar, Insider: sold $3.8M (3 sales), last Apr 2, 2026
- Mike Kelliher, Insider: other filings, last Jan 5, 2026
- Philip J Gotwals, Insider: other filings, last Jan 5, 2026
- George W Dunbar Jr, Insider: other filings, last Jan 5, 2026
- Linda Marban, CEO: other filings, last Jan 5, 2026
- David B Musket, Insider: other filings, last Jan 5, 2026
- Paul Gisbert Auwaerter, Insider: other filings, last Jan 5, 2026
Get free alerts when an insider at Capricor Therapeutics, Inc files a new trade →